Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT02694822
Brief Title: AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

First Submitted : February 12, 2016
First Submitted that Met QC Criteria : February 24, 2016
First Posted : March 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 28, 2022
Last Update Posted : April 29, 2022